Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Palbociclib Treatment Patterns and Outcomes in HR+/HER2- MBC: Flatiron Database Analysis

NCT06495164 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT06495164
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06495164 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Palbociclib Treatment Patterns and Outcomes in HR+/HER2- MBC: Flatiron Database Analysis
Lead sponsor
Pfizer
Phase
Observational
Overall status
Active, not recruiting
Start date
June 24, 2024
Completion date
December 30, 2026
Enrollment
1 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, malignant neoplasm of breast